Cite

    Dollerup, O. et al. (2018). A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects. American journal of clinical nutrition. 108 (2), pp. 343-353. [Online].